R&D channel feed – Endpoints News

R&D channel feed

J&J clears PhII for rare blood disorder with drug from $6.5B Momenta buyout

3 years ago

Idorsia's brain bleed drug flunks PhIII trial, a decade after previous flop

3 years ago

Sanofi scraps PhIII trial for Principia drug after reviewing competition

3 years ago

Magenta halts stem cell work and may sell itself following patient death, clinical hold

3 years ago

How to use external controls: FDA spells out thinking in new draft guidance

3 years ago

The Big Pharma axe: Merck cuts chikungunya vax, Bristol Myers drops CytomX-partnered program, and more

3 years ago

Karuna licenses Goldfinch assets to compete with Boehringer Ingelheim in neuroscience

3 years ago

Roche ditches final PhIII for cancer hopeful, reports setback for key drug in $1.4B buyout

3 years ago

Prothena unveils healthy volunteer safety data for Alzheimer's drug in Bristol Myers collab

3 years ago

KKR healthcare vet Jim Momtazee’s investment firm closes $3.9B inaugural fund

3 years ago

Simba Gill staying on at Evelo to weather layoffs and a PhII fail

3 years ago

GSK drops celiac drug, anti-bacterial vaccine in latest pipeline sweep

3 years ago

Updated: Novartis rejigs late-stage plans for Cosentyx, next-gen CAR-T, TIGIT antibody and more

3 years ago

Cell therapy biotech shifts focus to UK, makes deep cuts to US headcount

3 years ago

Novartis' Xolair successor hit by another PhIII axe, but food allergy study continues

3 years ago

Pfizer cuts eight programs, including dwarfism drug at center of Therachon buyout

3 years ago

Small Nebraska startup hopes to challenge Pfizer, Merck in pneumococcal vaccine race

3 years ago

Inovio’s decades of shifting extends to wayward winter in pipeline, workforce thinning

3 years ago

New York City invests $20M into biotech 'innovation space' at the Brooklyn Navy Yard

3 years ago

Boehringer Ingelheim touts prevention results in rarest form of psoriasis

3 years ago

‘The field is at a flashpoint’: New Chad Mirkin-founded biotech hopes to make more effective cancer vaccines

3 years ago

CureVac touts older adult data for GSK-partnered Covid-19, flu candidates

3 years ago

Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma

3 years ago

Novartis' approved sickle cell disease drug fails to beat placebo in PhIII

3 years ago

First page Previous page 98 99 100101102 103 104 Next page Last page